KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Invested Capital (2018 - 2025)

Amneal Pharmaceuticals (AMRX) has 8 years of Return on Invested Capital data on record, last reported at 0.3% in Q4 2025.

  • For Q4 2025, Return on Invested Capital changed 0.0% year-over-year to 0.3%; the TTM value through Dec 2025 reached 0.3%, changed 0.0%, while the annual FY2025 figure was 11.61%, 1189.0% down from the prior year.
  • Return on Invested Capital reached 0.3% in Q4 2025 per AMRX's latest filing, up from 0.13% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.3% in Q3 2021 and bottomed at 0.09% in Q2 2022.
  • Average Return on Invested Capital over 5 years is 0.11%, with a median of 0.09% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: soared 135bps in 2021, then tumbled -35bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 0.06% in 2021, then tumbled by -162bps to 0.03% in 2022, then skyrocketed by 377bps to 0.1% in 2023, then surged by 211bps to 0.3% in 2024, then fell by -1bps to 0.3% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.3% in Q4 2025, 0.13% in Q3 2025, and 0.1% in Q2 2025.